Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Nvidia, Apple, Microsoft And Others Set To Lose As Gartner Predicts Demand Softness For Smartphones, PCs In 2022

China's economic slowdown and inflation-led drop in consumer spending will likely weigh on the global shipments of computers and smartphones in 2022, as per a Reuters story citing research firm Gartner. Earlier this month, Advanced Micro Devices, Inc (NASDAQ:AMD) warned against a slowdown in the PC market after two solid years. Analysts expected the chipmaker to gain…

Benzinga

NeuroSense Shares Surge On Encouraging Data From Alzheimer's-Associated Biomarker Study

NeuroSense Therapeutics Ltd (NASDAQ:NRSN) has announced results from a biomarker study to evaluate the potential of CogniC, a combination drug for Alzheimer's disease (AD). Earlier this week, NeuroSense reported results from a stage III ALS Biomarker study evaluating PrimeC. Preliminary results showed that levels of disease-related biomarkers in people with ALS were unchanged, in contrast…

Benzinga

The Daily Biotech Pulse: Pfizer/BioNTech Ink New COVID-19 Vaccine Supply Pact, Sanofi Hit By FDA Clinical Hold, Angion Biomedica Halts Second Kidney Disease Trial

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Stocks Under $2 Insiders Are Aggressively Buying

U.S. stock futures traded lower this morning on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or…

Benzinga

Walgreens Posts Fall In Q3 Profit On Opioid Settlement, Lower Pharmacy Sales

Walgreens Boots Alliance Inc's (NASDAQ:WBA) Q3 FY22 sales decreased 4.2% Y/Y to $32.6 billion, down 2.8% on a constant currency basis, beating the consensus of $32.06 billion. Adjusted EPS reached $0.96, beating the consensus of $0.92, down 28.9% on a constant currency basis against 93.6% growth a year ago that reflected peak…

Benzinga

It's been a vicious 6 months for stocks. Here's what the grim markets are signaling

All that whipsawing on Wall Street in the first half of the year reflects real nervousness. Investors are worried the Fed may tip the economy into a recession.

WEKU

3 Stocks Insiders Are Buying: Children's Place And More

Although US stocks closed mixed on Wednesday, there were a few notable insider trades.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Benzinga Before The Bell: Texas Giga Tesla's Output Ramp Up, California's Lithium Tax, Spot Bitcoin ETF Proposal Rejection And Other Top Financial Stories Thursday, June 30

Reuters Hyundai, Affiliates Plan To Set Up New Company In US:

Benzinga

Recap: Simply Good Foods Q3 Earnings

Simply Good Foods (NASDAQ:SMPL) reported its Q3 earnings results on Thursday, June 30, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

This Stock May Rally Even As Other Chip Stocks Dip

Micron Technology, Inc. (NASDAQ: MU) is scheduled to report its quarterly earnings after the closing bell on June 30.

Benzinga

Avadel Cuts Workforce, Optimizes Cost Structure To Support This

Avadel Pharmaceuticals plc (NASDAQ: AVDL) announced its steps to explore every available pathway to accelerate the FDA approval of its lead drug candidate, FT218, before June 2023.

Benzinga

Xerox Names COO Steve Bandrowczak As Interim CEO After John Visentin Dies Due To Ongoing Illness

Xerox Holdings Corp (NASDAQ:XRX) CEO John Visentin abruptly passed away on June 29 due to complications from an ongoing illness. Since joining Xerox in May 2018, John has been known for his "One Boat, One Team" call to action and mentality. COO Steve Bandrowczak will serve as interim CEO. Xerox registered a first-quarter FY22 sales…

Benzinga

Canopy Growth Enters Into Exchange Agreements With Holders Of Approximately $198M Of Convertible Notes

Canopy Growth Corporation (NASDAQ: CGC) (TSX:WEED) has entered into privately negotiated exchange agreements with a limited number of holders, including Constellation Brands, Inc. (NYSE: STZ) through its wholly-owned s

Benzinga

Coinbase To Merge USD, USDC Order Books For 'Deeper Liquidity'

Crypto exchange Coinbase Global Inc (NASDAQ: COIN) plans to merge its U.S. dollar order book with its USD Coin (CRYPTO: USDC) order book.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Nexstar Nears Deal To Snap Majority Control In CW Network: WSJ

Nexstar Media Group, Inc (NASDAQ:NXST) is on the verge of acquiring majority control of the CW Network from Warner Bros. Discovery, Inc (NASDAQ:WBD) and Paramount Global (NASDAQ:PARA), the Wall Street Journal reports. The leading owner of local television stations would acquire 75% of the CW, a broadcast network aimed primarily at teens and young adults, with…

Benzinga

AstraZeneca Says Imfinzi/Chemo Combo Shows Promising Action In Late-Stage Lung Cancer Study

AstraZeneca Plc (NASDAQ:AZN) announced high-level results from a planned interim analysis of the AEGEAN Phase 3 trial of Imfinzi (durvalumab) combined with neoadjuvant chemotherapy in patients with resectable non-small cell lung cancer (NSCLC). The data showed that Imfinzi plus neoadjuvant chemo before surgery demonstrated a statistically significant and meaningful improvement in pathologic complete…

Benzinga

Why Sanofi Shares Are Falling Today

The FDA has placed Sanofi SA's (NASDAQ:SNY) Phase 3 studies of tolebrutinib in multiple sclerosis and myasthenia gravis on partial clinical hold. New enrollment in the U.S. is paused, and participants in the U.S. who have been in the trial for fewer than 60 days shall suspend the study drug. The participants who…

Benzinga

Read How Avid Bioservices Fared In Q4

Avid Bioservices Inc (NASDAQ:CDMO) reported Q4 FY22 sales of $31.2 million, up 13% Y/Y, beating the consensus of $28.96 million. The growth is attributed to an increase in the scope of in-process and completed manufacturing runs and process development revenues. The company signed multiple new project orders during Q4 totaling approximately $44…

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

iPhone Turns 15: How Much Return $100 Investment In Apple Stock At Launch Would Have Fetched For You

The first iPhone was put on sale by Apple Inc (NASDAQ: AAPL) 15 years ago.

Benzinga

Elon Musk's Giga Texas Worries May Ease As Tesla Factory Said To Significantly Ramp Up Output

Tesla Inc (NASDAQ: TSLA) has been able to ramp up production at Giga Texas to thousands of units per week, Electrek reported&nbs

Benzinga

Aspen Aerogels And 28 Stocks Moving Premarket

Gainers

Benzinga

MillerKnoll Q4 Earnings Beat Street View

MillerKnoll Inc (NASDAQ:MLKN) reported fourth-quarter FY22 sales growth of 77% year-on-year to $1.10 billion, beating the consensus of $1.09 billion. Orders in Q4 rose 47% to $1.01 billion. The gross margin for the quarter contracted 160 basis points Y/Y to 34.8%. The operating expenses rose 51.5% Y/Y to $325.5 million. The operating margin…

Benzinga

Angion Biomedica Pulls The Plug On Another Kidney Disease Trial - Read Why

Angion Biomedica Corp (NASDAQ:ANGN) has discontinued the JUNIPER Phase 2 trial of ANG-3070, an oral tyrosine kinase inhibitor, in primary proteinuric kidney diseases, specifically focal segmental glomerulosclerosis and immunoglobulin A nephropathy. The trial began enrolling patients in December 2021. A reassessment was conducted following a potential safety signal of an unexpected and substantial…

Benzinga

US Stock Futures Down Ahead Of Jobless Claims Data

Pre-open movers

InsideEVs

Polestar Shares Down 25 Percent Four Days After Nasdaq Debut

Polestar rang the Nasdaq opening bell on June 28.

1 … 385 386 387 388

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.